Richard van Wijk
Overview
Explore the profile of Richard van Wijk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
130
Citations
1823
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
van Dijk M, Traets M, van Oirschot B, Ruiter T, de Wilde J, Bos J, et al.
EJHaem
. 2024 Feb;
5(1):21-32.
PMID: 38406513
The most common forms of sickle cell disease (SCD) are sickle cell anemia (SCA; HbSS) and HbSC disease. In both, especially the more dense, dehydrated and adherent red blood cells...
12.
Al-Samkari H, Shehata N, Lang-Robertson K, Bianchi P, Glenthoj A, Sheth S, et al.
Lancet Haematol
. 2024 Feb;
11(3):e228-e239.
PMID: 38330977
Pyruvate kinase (PK) deficiency is the most common cause of chronic congenital non-spherocytic haemolytic anaemia worldwide, with an estimated prevalence of one in 100 000 to one in 300 000...
13.
Houwing M, Bos J, van Wijk R, van Beers E, Cnossen M, Rab M
Int J Lab Hematol
. 2023 Dec;
46(2):390-394.
PMID: 38105480
No abstract available.
14.
van Dijk M, de Wilde J, Bartels M, Kuo K, Glenthoj A, Rab M, et al.
Blood Rev
. 2023 Dec;
64:101160.
PMID: 38044254
No abstract available.
15.
Rab M, Kanne C, Boisson C, Bos J, van Oirschot B, Houwing M, et al.
Blood Adv
. 2023 Nov;
8(2):276-286.
PMID: 37976458
We investigated the potential of the point of sickling (PoS; the pO2 tension at which red cells start to sickle), determined by oxygen gradient ektacytometry to serve as a biomarker...
16.
Pagnamenta A, Camps C, Giacopuzzi E, Taylor J, Hashim M, Calpena E, et al.
Genome Med
. 2023 Nov;
15(1):94.
PMID: 37946251
Background: Whole genome sequencing is increasingly being used for the diagnosis of patients with rare diseases. However, the diagnostic yields of many studies, particularly those conducted in a healthcare setting,...
17.
van Dijk M, Rab M, van Oirschot B, Bos J, Derichs C, Rijneveld A, et al.
Blood Adv
. 2023 Nov;
7(24):7539-7550.
PMID: 37934880
Targeting the primary pathogenic event of sickle cell disease (SCD), the polymerization of sickle hemoglobin (HbS), may prevent downstream clinical events. Mitapivat, an oral pyruvate kinase (PK) activator, has therapeutic...
18.
van Dijk M, van Oirschot B, Harrison A, Recktenwald S, Qiao M, Stommen A, et al.
Am J Hematol
. 2023 Sep;
98(12):1877-1887.
PMID: 37671681
Adenosine Triphosphatase (ATPase) Phospholipid Transporting 11C gene (ATP11C) encodes the major phosphatidylserine (PS) flippase in human red blood cells (RBCs). Flippases actively transport phospholipids (e.g., PS) from the outer to...
19.
van Dijk M, de Wilde J, Bartels M, Kuo K, Glenthoj A, Rab M, et al.
Blood Rev
. 2023 Jun;
61:101103.
PMID: 37353463
Novel developments in therapies for various hereditary hemolytic anemias reflect the pivotal role of pyruvate kinase (PK), a key enzyme of glycolysis, in red blood cell (RBC) health. Without PK...
20.
Delamare M, Le Roy A, Pacault M, Schmitt L, Garrec C, Maaziz N, et al.
Haematologica
. 2023 Jun;
108(11):3068-3085.
PMID: 37317877
Hereditary erythrocytosis is a rare hematologic disorder characterized by an excess of red blood cell production. Here we describe a European collaborative study involving a collection of 2,160 patients with...